Ebos Group Share Price and Company Fundamentals
Last traded: Today at 5:10 AM
EBOS Group Limited engages in the marketing, wholesale, and distribution of healthcare, medical, pharmaceutical, and animal care products in Australia, Southeast Asia, and New Zealand. It operates through Healthcare and Animal Care segments. The company provides healthcare logistics; medication management solutions; pharmacy management software; loyalty, generics, compliance, business intelligence, and store software services; and health communications, programs, and consultancy services. It also offers community based health care services and programs; vitamins, minerals and supplements, herbal and fruit teas, and natural toothpastes, as well as functional foods, including molasses and manuka honey; Pharmacy Choice, a five step integrated retail program for independent pharmacies; and healthSAVE, a community pharmacy banner that helps members drive their retail businesses. Further, it offers healthcare distribution, warehousing, clinical trial management, and product registration services; clinical trial logistics; aesthetic healthcare devices, medical-grade cosmeceuticals, and injectables; and surgical devices and medical consumables. Additionally, the company provides pet nutrition, treats, clean-up, and grooming products and accessories; and wholesales veterinary products. The company was formerly known as Early Bros Dental & Surgical Supplies Ltd. and changed its name to EBOS Group Limited in 1986. EBOS Group Limited was incorporated in 1922 and is headquartered in Docklands, Australia.
Key Metrics
PE ratio
21.60
PB ratio
1.62
Dividend yield
4.50%
Beta
0.21
Market cap
$4.49B
Enterprise value
$5.86B
Company profile
| Industry / Sector | Medical Distribution / Healthcare |
|---|---|
| Full time employees | 5770 |
| Website | https://www.ebosgroup.com |
| Mailing address | 737 Bourke Street Level 7 Docklands VIC 3008 Australia |
| Phone / Fax | 61 3 9918 5555 / 61 3 9918 5599 |
Dividends
More: Ebos Group Dividend history, yield and payout ratio
Dividend yield
4.50%
Dividend amount
$0.98
Payout ratio
89.84%
5Y Avg. yield
-%
Ebos Group paid $0.98 dividend and the ex-dividend date was 04 Sep 2025.The dividend payout ratio is 89.84%. The dividend payout ratio is defined as the amout of dividend paid divided by the earnings of the company.EBO dividend payout ratio is between 70-90%. The lower dividend payout ratio is preferrable since it provides company margin to grow the dividends in future.
Company Executives
As of Feb 2026, following are the company executives and directors listed on Ebos Group.
| Name | Title | Age | Total Pay |
|---|---|---|---|
| Mr. Adam Luke Hall B.Com., BCOMM, L.L.B., LLB (HONS), M.B.A. | Chief Executive Officer | 50 | |
| Mr. Alistair Gray | Chief Financial Officer | ||
| Mr. Leonard Hansen | Chief Accountant & Chief Risk Officer | ||
| Mr. Mithran Naiker | Chief Information Officer | ||
| Ms. Janelle Cain | General Counsel | ||
| Mr. Martin Krauskopf | Chief Strategy & Corporate Development Officer | ||
| Ms. Jacinta McCarthy | Executive General Manager of Human Resources | ||
| Mr. Simon Bunde | Executive General Manager of Strategic Operations, ESG & Innovation | ||
| Mr. Grant Viney | Chief Executive Officer of EBOS Animal Care | ||
| Ms. Kristine James | CEO of Medical Technology |
Profitability and management effectiveness
Profit margin
1.75%
Operating margin
3.33%
Return on assets
3.78%
Return on equity
8.39%
Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.
The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.
Valuation and Trading Info
The market capitalization of Ebos Group is 4.49B and its enterprise value is 5.86B. The enterprise value to revenue ratio of EBO is 0.48. The enterprise value to EBITDA ratio of EBO is 11.64.
The EBO's stocks Beta value is 0.21 making it 79% less volatile compared to ASX market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.
Companies similar to Ebos Group (EBO)
- Ansell (ANN)
- Cochlear (COH)
- Estia Health (EHE)
- Fisher & Paykel Healthcare Corporation (FPH)
- Healius (HLS)
- Nanosonics (NAN)
- Pro Medicus (PME)
- Polynovo (PNV)
- Ramsay Health Care (RHC)
- Resmed Inc (RMD)
- Sonic Healthcare (SHL)
Ebos Group (ASX:EBO) Frequently Asked Questions
1. What is Ebos Group's Stock Symbol?
Ebos Group trades on ASX under the ticker symbol "EBO".
2. What is Ebos Group's stock price today?
One share of EBO stock can currently be purchased for approximately $21.82.
3. How can I contact Ebos Group?
Ebos Group's mailing address is 737 Bourke Street Level 7 Docklands VIC 3008 Australia. The company can be reached via phone at 61 3 9918 5555.
4. What is Ebos Group's official website?
The official website of Ebos Group is https://www.ebosgroup.com.